1. Homepage
  2. Equities
  3. France
  4. Euronext Paris
  5. ERYTECH Pharma S.A.
  6. News
  7. Summary
    ERYP   FR0011471135

ERYTECH PHARMA S.A.

(ERYP)
  Report
Real-time Euronext Paris  -  11:35 2022-08-05 am EDT
1.210 EUR   -0.74%
08/05European ADRs Move Lower in Friday Trading
MT
08/04European ADRs Move Higher in Thursday Trading
MT
08/03European ADRs Nudge Higher in Wednesday Trading
MT
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

European ADRs Fall Sharply Lower in Monday Trading

06/13/2022 | 11:09am EDT


© MT Newswires 2022
Stocks mentioned in the article
ChangeLast1st jan.
AKARI THERAPEUTICS, PLC 1.43% 1.4301 Delayed Quote.-4.66%
AMARIN CORPORATION PLC 0.78% 1.29 Delayed Quote.-61.72%
AUTOLUS THERAPEUTICS PLC 7.08% 3.48 Delayed Quote.-32.95%
AVADEL PHARMACEUTICALS PLC 13.51% 5.88 Delayed Quote.-27.23%
CARNIVAL CORPORATION 0.72% 9.82 Delayed Quote.-51.19%
CELLECTIS S.A. 9.44% 3.27 Real-time Quote.-56.05%
DBV TECHNOLOGIES 4.77% 5.115 Real-time Quote.67.21%
ERYTECH PHARMA S.A. -0.74% 1.21 Real-time Quote.-42.92%
FRESENIUS MEDICAL CARE AG & CO. KGAA 1.74% 36.91 Delayed Quote.-35.40%
FRESENIUS SE & CO. KGAA 1.32% 24.55 Delayed Quote.-30.65%
GENFIT 1.23% 4.264 Real-time Quote.-1.20%
SEQUANS COMMUNICATIONS S.A. -3.70% 3.64 Delayed Quote.-23.21%
VERONA PHARMA PLC 8.94% 6.7 Delayed Quote.-0.30%
All news about ERYTECH PHARMA S.A.
08/05European ADRs Move Lower in Friday Trading
MT
08/04European ADRs Move Higher in Thursday Trading
MT
08/03European ADRs Nudge Higher in Wednesday Trading
MT
07/28European ADRs Decline in Thursday Trading
MT
07/22European ADRs Edge Higher in Friday Trading
MT
07/13European ADRs Move Higher in Wednesday Trading
MT
07/11European ADRs Move Lower in Monday Trading
MT
07/07European ADRs Move Higher in Thursday Trading
MT
07/06European ADRs Move Lower in Wednesday Trading
MT
06/30ERYTECH PHARMA S.A. : Monthly statement on outstanding equity shares and voting rights
CO
More news
Analyst Recommendations on ERYTECH PHARMA S.A.
More recommendations
Financials
Sales 2022 9,20 M 9,34 M 9,34 M
Net income 2022 -52,8 M -53,6 M -53,6 M
Net Debt 2022 1,50 M 1,52 M 1,52 M
P/E ratio 2022 -0,54x
Yield 2022 -
Capitalization 37,5 M 38,1 M 38,1 M
EV / Sales 2022 4,24x
EV / Sales 2023 2,39x
Nbr of Employees 181
Free-Float 98,5%
Chart ERYTECH PHARMA S.A.
Duration : Period :
ERYTECH Pharma S.A. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends ERYTECH PHARMA S.A.
Short TermMid-TermLong Term
TrendsBullishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus SELL
Number of Analysts 1
Last Close Price 1,21 €
Average target price 3,60 €
Spread / Average Target 198%
EPS Revisions
Managers and Directors
Gil Beyen Chief Executive Officer & Director
Eric Soyer Chief Operating & Financial Officer
Jean-Paul Kress Chairman
Iman El-Hariry Chief Medical Officer
Stewart Craig Chief Technical Officer
Sector and Competitors
1st jan.Capi. (M$)
ERYTECH PHARMA S.A.-42.92%38
GILEAD SCIENCES, INC.-15.87%76 626
VERTEX PHARMACEUTICALS31.16%73 868
REGENERON PHARMACEUTICALS, INC.-2.84%65 600
BIONTECH SE-28.97%44 499
WUXI APPTEC CO., LTD.-19.26%41 093